Metric Analysis: Oruka Therapeutics Inc (ORKA)’s Key Ratios in the Limelight

Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Oruka Therapeutics Inc (NASDAQ: ORKA) closed at $20.26 up 8.40% from its previous closing price of $18.69. In other words, the price has increased by $8.40 from its previous closing price. On the day, 51276.0 shares were traded. ORKA stock price reached its highest trading level at $20.26 during the session, while it also had its lowest trading level at $18.5.

Ratios:

For a deeper understanding of Oruka Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 22.89 and its Current Ratio is at 22.89. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on October 11, 2024, initiated with a Buy rating and assigned the stock a target price of $49.

On October 07, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $45.

On September 17, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $44.Leerink Partners initiated its Outperform rating on September 17, 2024, with a $44 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 16 ’24 when JANUS HENDERSON GROUP PLC bought 5,818 shares for $2.93 per share. The transaction valued at 17,067 led to the insider holds 2,117,213 shares of the business.

JANUS HENDERSON GROUP PLC bought 189,856 shares of ORKA for $606,873 on Jul 24 ’24. The 10% Owner now owns 2,081,168 shares after completing the transaction at $3.20 per share. On Jul 25 ’24, another insider, JANUS HENDERSON GROUP PLC, who serves as the 10% Owner of the company, bought 30,227 shares for $3.05 each. As a result, the insider paid 92,292 and bolstered with 2,111,395 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORKA now has a Market Capitalization of 709071616.

Stock Price History:

Over the past 52 weeks, ORKA has reached a high of $33.00, while it has fallen to a 52-week low of $10.07. The 50-Day Moving Average of the stock is -21.34%, while the 200-Day Moving Average is calculated to be -4.50%.

Shares Statistics:

For the past three months, ORKA has traded an average of 112.92K shares per day and 243050 over the past ten days. A total of 35.00M shares are outstanding, with a floating share count of 30.11M. Insiders hold about 13.96% of the company’s shares, while institutions hold 60.26% stake in the company.

Most Popular